|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 18.10 USD | -1.55% |
|
-4.27% | +4.83% |
| 03-06 | Tylenol use among women dropped after Trump tied it to autism, Lancet analysis shows | RE |
| 03-05 | Barclays Adjusts Price Target on Kenvue to $19 From $18, Maintains Equalweight Rating | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
Past dividends on Kenvue Inc.
| 10/02/2026 | Quarterly 0.2075 USD |
| 11/11/2025 | Quarterly 0.2075 USD |
| 12/08/2025 | Quarterly 0.2075 USD |
| 13/05/2025 | Quarterly 0.205 USD |
| 11/02/2025 | Quarterly 0.205 USD |
| 12/11/2024 | Quarterly 0.205 USD |
| 13/08/2024 | Quarterly 0.205 USD |
| 06/05/2024 | Quarterly 0.2 USD |
| 12/02/2024 | Quarterly 0.2 USD |
| 06/11/2023 | Quarterly 0.2 USD |
| 24/08/2023 | Quarterly 0.2 USD |
- Stock Market
- Equities
- KVUE Stock
- Charts Kenvue Inc.
- Total Return chart
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition